The Form 4 filing, an SEC report of an insider's stock trades, was filed on November 12, 2026. It lists November 9 as the sale date for David Abraham Gilboa, Warby Parker's co-chief executive officer. The filing came three days after the trade.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-09 |
| Date of Latest Transaction | 2026-11-09 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 75,402 |
| Price | $29.82 |
| Total Transaction Value | $2,248,487.64 |
| Insider | |
| Ticker Symbol | WRBY |
| Company | Warby Parker Inc. |
| Insider Name | Gilboa David Abraham |
| Insider Title | Co-Chief Executive Officer |
| Sector - Industry | Healthcare - Medical Instruments & Supplies |
| Holdings | |
| Total Shares Owned After Transaction | 40,406 |
| Position Size Change | 65.11% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of Warby Parker (WRBY) shares by David Abraham Gilboa. It carries transaction code S, which identifies a sale. The filing lists one transaction.
What was the average price of the transaction?
The average sale price was $29.82 per share.
How did this transaction affect the insider's holdings?
He sold 75,402 shares and reported 40,406 shares owned afterward. The sale covered 65.11% of the shares held before the trade in the reported share balance.
What's the total transaction value?
The total value of the single reported sale was $2,248,487.64.
Are there any special circumstances around this transaction?
The transaction information includes a Rule 10b5-1 trading-plan reference. These plans set trading instructions ahead of time. Footnote text is unavailable, so the reference's scope within the filing is unknown. Whether it covered this specific sale remains unclear. The plan's terms and the date it was set up are also unknown.
For research purposes only; not investment advice.